Genetic Variation of Promoter Sequence Modulates XBP1 Expression and Genetic Risk for Vitiligo
Figure 4
XBP1 protein level determined by immunohistochemical staining in the paired lesional and non-lesional skins from 37 patients with vitiligo.
Data represent the percentage of positive cells. The comparison of XBP1 protein level between the 37 paired lesional and non-lesional skins was done by using Paired Samples T Test.